What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.









Hear from our Alumni:

“CaNCURE has granted me the opportunity to conduct independent cancer research, by providing me with a strong foundational education in nanomedicine as well as exceptionally experienced mentorship.”

Joseph Nneji, Biochemistry, ’16

Trainee Spotlight

Abigail Cohen

Health Sciences, '20

In Vivo Treatment of Established HGSOC Line Using Novel Therapy

Nayoon "Julie" Kim

Chemical Engineering and Biochemistry, '21

Codelivery of tumor suppressor mRNA and anti-cancer drug in cancer treatment

Esteban Enrique

Biochemistry, '20

Assessing sufficiency of the Tip60/p400 complex in inducing transcription of Merkel Cell Polyomavirus Small T antigen target genes.

Featured Trainee Publication

Upcoming Events

Check back soon for new events

Mentor Spotlight

Zdravka Medarova, Ph.D.

Associate Professor in Radiology, MGH/MIT/HMS

The focus of my research has been the development and testing of multi-functional imaging/delivery vehicles for combined cancer imaging and therapy. More recently, our lab developed magnetic nanoparticles as delivery vehicles of miRNA-targeted therapy to breast tumors.

Ciprian Catana, M.D., Ph.D.

Associate Professor in Radiology , HMS

Our laboratory seeks to improve the quantification of the PET data using the simultaneously acquired MR information in integrated MR-PET scanners. Students will have the opportunity to use advanced MR-PET methods to study the delivery, mechanism of action and effects of therapeutic agents in cancer patients.

Trainee Spotlight

Kaylie DeCosmo

Health Sciences, '20

Nanoparticle-aided radio-immunotherapy

Nayoon "Julie" Kim

Chemical Engineering and Biochemistry, '21

Codelivery of tumor suppressor mRNA and anti-cancer drug in cancer treatment

Anthony Alvarez

Health Sciences, '20

Targeted Delivery of Talazoparib to Treat Non-Small Cell Lung Cancer

 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...